from the following major changes: Shareholders' Equity Items that has significant changes Balance by Quarter Change Q3–23 Q4–22 Q3–23 VS Q4–22 (MB) (MB) % Issued and fully paid-up 1,431.4 1,331.1 100.3
entitled to one vote. In the event of a tied vote, the chairman of the meeting may exercise a casting vote. Clause 13. In performing the power and duty of the administrative panel or the SEC which is not an
of December 31, 2017 was Baht 1,029.03 million increased Baht 369.94 million as of December 31, 2016 due to the increase of paid-up capital which equivalent to Baht 65.3 million and share premium from
31, 2017 from the increase of paid-up capital which equivalent to Baht 32.35 million together with share premium from the exercising of ECF-W1 that expired in the year 2018 at the exercise price Baht
% of paid up capital, Total investment 50 Millions baht. The acquisition of BS Myco Biotech shares will result in the BS Myco Biotech being a subsidiary of the Company. The Company signed the share
listed company as consideration / Number of paid-up shares of the listed company (This calculation basis is not applicable) - Highest Transaction Size 32.21% 5. Details of Assets Acquired Trans.Ad’s shares
. Which the company will sign the share purchase agreement on July 24, 2019. Details of such items appear in Attachment 1: Information Memorandum Concerning the Disposition of Assets Please be informed
the case of exercise the Right of Investment in Laemchabang International Ro-Ro Terminal Co., Ltd. ("LRT”) by to the purchase of 29 percent of shares of NYKT International Terminal Co., Ltd. from Nippon
details are as follows: 1. Transaction Date : To sign the share purchase agreement by January 31, 2020 and the purchase transaction is expected to be completed by March 2020 2. Relevant parties and relation